Endometriosis: If we utilise all the knowledge we have about cancer, there is reason to hope that effective diagnosis and treatments can be developed to combat the female condition ‘everybody’ is talking about.
A radioactive tracer is being tested for the first time in Norway at St. Olavs Hospital and NTNU. The goal is to improve the detection of dementia diseases.
It has taken 18 years, but Professor Marit Otterlei has now created a completely new type of cancer medicine. No similar medication has progressed this far in development worldwide.
A simple test saves lives. Three out of four women who died of cervical cancer in the screening age of 25-69 years had not had a Pap smear in the past three and a half years.
Some people feel worse than others after a stroke. Stroke patients with cognitive and emotional problems tend to experience fatigue more often and sleep more during the day, according to recent research.
Machines are currently learning how to identify cancer cells with the help of manipulated light. This approach may help to take the pressure off our hard-pressed health services and reduce waiting times for anxious patients.
Paradoxical maybe, but it’s what often happens in the health services: When you ask for an MRI to be on the safe side, your uncertainty increases.
Stroke patients who experience delirium during a stroke could be more prone to developing cognitive and psychiatric difficulties.
Not everyone with diabetes knows they have the disease. A survey of close to 53 000 participants found that far more people are being discovered with diabetes than was previously thought.
Combining ultrasound and bubbles helps medicines pass through the protective blood-brain barrier and is giving hope for improved treatment of several diseases.
Researchers have discovered a new method of activating enzymes that may make it possible to repair proteins that have been damaged as a result of hereditary diseases, such as some types of skin cancer.
Researchers are creating molecules that can slow down the development of osteoporosis, cancer and inflammation. Foreign investors are interested.
Lung cancer is one of the most dangerous forms of cancer. Treatments are available, but they are demanding on patients and less than 30 percent survive. But mRNA technology is offering new hope for higher survival rates because treatments target the malignant cells in an entirely new way.
Many people who experience problems with memory after a stroke regain their memory within three months.
The underlying cause of many cardiovascular diseases is inflammation of the artery walls. Now NTNU researchers have found that a specific neurotransmitter in the immune cells is a key factor when cholesterol accumulates in our blood vessels.
New findings show how experiments with animals can provide helpful information to understand Alzheimer’s and learn how we can better fight the disease.
Researchers are on the trail of a new method to protect against heart damage after cancer treatment.
Rheumatoid arthritis (RA) is both bothersome and painful. Less well known is the risk of premature death, because the disease can contribute to a less healthy lifestyle.
After conducting the largest study on osteoarthritis in the world, researchers are now on track to develop a medicine that can slow it down.
For the first time, researchers have shown how cancer cells reprogram themselves to produce lactic acid and to tolerate the acidic environment that exists around tumours. The finding could lead to a whole new direction for treating cancer.
Much more research has been done on eating problems in girls than in boys. There are major differences between the genders when it comes to symptoms and bodies, and the same technique is not as suited to detecting problems in boys, says NTNU researcher Farzaneh Saeedzadeh Sardahaee.
NTNU master’s student Vanessa Solvang cultivates tiny little beating hearts in the lab. She takes good care of them, weekends included.
The risk of dying from heart disease, chronic lung disease or diabetes in adulthood is twice as high for preemies —premature infants — as for the general population. Even those who were born just two to three weeks before term have a slightly increased risk.
Bone marrow cancer is currently an incurable disease that affects about 400 people in Norway every year. Professor Therese Standal at NTNU has now found an important reason for bone destruction in people with this disease.
